German pharma manufacturer scaling OTC and nutritional brands across 60+ countries
Queisser Pharma is a 125-year-old self-owned pharmaceutical manufacturer based in Flensburg, operating across OTC medicines, medical devices, supplements, and cosmetics under eight brands (Doppelherz, Tiger Balm, Bi-Oil, and others). The hiring mix—weighted toward junior sales, HR, and marketing roles—reflects a company in expansion mode: concurrent projects span employer branding, HR digitalization, and market entry strategy, while pain points center on procurement efficiency and sales territory optimization, suggesting infrastructure strain from geographic growth.
Queisser Pharma manufactures and distributes health and wellness products across consumer segments in Germany and globally. The portfolio spans over 150 SKUs across OTC pharmaceuticals, nutritional supplements, medical devices, and topical products. Distribution reaches more than 60 countries; the company operates subsidiaries in Bulgaria, Romania, Turkey, Russia, Ukraine, and Poland as dedicated import and sales partners. In Germany, a 50-person field sales team and physician liaison group form the core go-to-market engine. Tech infrastructure includes SAP, Infor, and OTRS; current operational priorities focus on supply-chain efficiency, sales planning automation, and workforce digitalization.
OTC pharmaceuticals, nutritional supplements (Doppelherz is the leading supplement brand in Germany), medical devices, cosmetics, and topical products across eight brands sold in 60+ countries.
Primary systems include SAP and Infor for enterprise operations, OTRS for customer support, Microsoft Office/Teams/Exchange for collaboration, VMware and Linux for infrastructure, and GCP for cloud services. HPLC is used in quality control workflows.
Other companies in the same industry, closest in size